Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

2 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-09-18

Study Completion Date

2018-02-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This retrospective, multi-center, chart review study will collect patient data from medical charts of pediatric patients who have been treated with Korlym for Cushing's syndrome.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome

NCT02663609

Cushing's Syndrome

COMPLETED

Long-Term Follow-Up of Survivors of Pediatric Cushing Disease

NCT03831958

Cushing Disease

RECRUITING

Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease

NCT04339751

Cushing's Disease

WITHDRAWN PHASE2

Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome

NCT03708900

Cushing Syndrome

RECRUITING PHASE2

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

NCT02804750

Cushing's Syndrome

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This retrospective chart review study seeks to collect data from pediatric patients treated with Korlym (mifepristone) to help provide clinicians with some insight on the potential role of mifepristone in the treatment of pediatric patients with Cushing syndrome.

Only sites that have been identified to have patients appropriate for this protocol will be invited to participate and contribute data on their patients

Data to be collected from a retrospective chart review will include:

* Patient demographics
* Medical history
* Pre and post treatment clinical assessments and laboratory results
* Radiologic findings (if available)
* Adverse events

Data will be collected for all follow-up visits, up until the most recent encounter prior to IRB approval.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypercortisolism Cushing Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pediatric Cushing Syndrome Patients

Pediatrics patients with endogenous Cushing syndrome who received at least one dose of Korlym

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatrics (age≤21 years) at time Korlym initiation
* Considered to have a diagnosis of endogenous Cushing's syndrome by the healthcare provider
* Received at least one dose of Korlym
* Availability of pre-treatment (baseline) and follow-up data